Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Second UK Phase III Anal Cancer Trial: A Trial of Chemoradiation and Maintenance Therapy for Patients With Anal Cancer

NCT00025090 is registered in ClinicalTrials.gov with University College London (UCL) Cancer Institute as lead sponsor.

NCT NCT00025090
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00025090 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Second UK Phase III Anal Cancer Trial: A Trial of Chemoradiation and Maintenance Therapy for Patients With Anal Cancer
Lead sponsor
University College London (UCL) Cancer Institute
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2001
Completion date
August 31, 2007
Enrollment
600 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

anal cancer